Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Aptamers in neuro-oncology: an emerging therapeutic modality
In particular, tell your provider if you have or have a past history of: Type 1 or type 2 diabetes Thyroid cancer Pancreatitis Kidney disease Diabetic retinopathy Depression Suicidal thoughts or behavior Ileus Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding
It is not a substitute for professional medical diagnosis or treatment
Activation of these cells stimulates the secretion of somatostatin, a potent inhibitor that acts locally on neighboring -cells to suppress glucagon release (Zheng et al., 2024)
The phase 2 clinical trial was conducted in the United States and included 281 participants
US$ 22.22
US$ 25.02
US$ 21.92
US$ 23.62
US$ 27.98
